187.15USD-2.12%Mkt Cap: 28.32B $P/E: 33.971d ago
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and arr…
Industry Peers
Diagnostics & Research$198.93BUSDP/E 29.4
$142.11BUSDP/E 38.9
$45.85BUSDP/E 44.2
$43.94BUSDP/E 41.0
$39.72BUSD
$38.05BUSDP/E 27.1
$36.81BUSDP/E 47.6
$34.52BUSDP/E 25.7
$26.60BUSDP/E 30.9
$22.34BUSDP/E 22.3
$22.30BUSDP/E 24.1
$21.61BUSD
$15.11BUSDP/E 33.3
$13.06BUSDP/E 27.3
$12.42BUSDP/E 53.5
$10.99BUSD
$9.26BUSDP/E 21.6
$5.97BUSDP/E 240.5
$5.77BUSD
$5.18BUSDP/E 44.3
$4.83BUSD
$4.75BUSDP/E 55.1
$3.75BUSDP/E 26.5
$3.19BUSD
$1.96BUSD
$1.89BUSD
$1.64BUSDP/E 41.7
$1.65BUSD
$1.48BUSDP/E 22.4
$1.54BUSD
$1.02BUSDP/E 21.4
$916.25MUSD
$906.11MUSD
$728.53MUSD
$616.40MUSDP/E 40.2
$596.70MUSD
$595.97MUSD
$293.12MUSDP/E 2.9
$288.48MUSD
$217.47MUSD
$155.64MUSD
$139.43MUSD
$103.89MUSD
$97.25MUSD
$89.37MUSDP/E 17.2
$73.19MUSD
$58.55MUSD
$45.11MUSD
$30.71MUSD
$26.61MUSD
$20.94MUSD
$16.60MUSD
$12.04MUSD
$9.95MUSD
$8.70MUSD
$9.12MUSD
$7.73MUSD
$7.43MUSD
$7.13MUSD
$6.06MUSD
$5.52MUSD
$4.54MUSD
$3.86MUSDP/E 2.8
$2.95MUSD
$3.20MUSD
$3.29MUSD
$2.79MUSD
$843.8KUSD
$314.2KUSDP/E Infinity
$19.6KUSD
Indicators:|
Key Statistics
Company
Market Cap28.32B $
Enterprise Value30.32B $
Revenue (TTM)4.39B $
Gross Profit2.87B $
Net Income (TTM)850.00M $
Revenue/Share28.62 USD
Last Price187.15 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8.6K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)33.97
P/E (Forward)32.26
PEG3.32
EV/EBITDA26.25
EV/Revenue6.90
P/S6.59
P/B10.86
EPS (TTM)5.49
EPS (Forward)5.93
52W Range
88.0091% of range196.66
52W High196.66 USD
52W Low88.00 USD
Profitability
Gross Margin66.08%
Oper. Margin18.33%
EBITDA Margin26.29%
Profit Margin19.57%
ROE31.22%
ROA12.79%
Growth
Revenue Growth4.80%
Earnings Growth6.10%
Cash Flow & Leverage
Operating CF1.08B $
CapEx (TTM)148.00M $
FCF Margin19.25%
FCF Yield2.99%
Net Debt1.39B $
Net Debt/EBITDA1.20
Balance Sheet
Debt/Equity0.94
Current Ratio1.75
Quick Ratio1.23
Book Value/Sh17.61 USD
Cash/Share7.634 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1028:1000
Split DateJun 25, 2024
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)159.32 USD
Upside (mean)-14.9%
Target Range95.00 USD – 200.00 USD
$95.00-14.9% to mean$200.00
# Analysts19
Ownership
Shares Out.151.30M
Float148.03M
Insiders0.20%
Institutions106.36%
Short Interest
Short Ratio3.6d
Short % Float8.17%
Short % Out.5.00%
Shares Short7.57M
Short (prev mo.)7.72M
Technical
SMA 50160.71 (+16.4%)
SMA 200132.93 (+40.8%)
Beta1.47
S&P 52W Chg20.37%
Avg Vol (30d)1.94M
Avg Vol (10d)1.97M
Technical Indicators
RSI (14)62.0
MACD8.9363
MACD Signal8.9751
MACD Hist.-0.0388
BB Upper203.03 USD
BB Middle178.79 USD
BB Lower154.54 USD
BB Width27.12%
ATR (14)6.887 USD
Vol Ratio (20d)0.87x